Health: Safety Trials For Insomniacs

Six of 10 American adults say they experience sleep problems on a weekly basis. Sleeping pills can help, but what are the risks of taking them night after night for months at a time? Most clinical trials study the effects over very short periods only. That's why there is so much interest in a new study sponsored by the drugmaker Sepracor and led by Dr. Andrew Krystal, director of Duke University's Sleep Research Laboratory and Insomnia Clinic. It monitored users of a Sepracor pill called Estorra (currently under review for approval by the FDA) in a double-blind, placebo-controlled study for six...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!